Indica Labs Announces Sneak Peek Webinar
Indica Labs: Learn about the exciting new features in the 2.5 versions of HALO AP®!
HALO AP 2.5 Sneak Peek Webinar
Date: 16 April 2026
Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 – 17:00 BST
Location: Webinar
Summary
Join Indica Labs for a 1-hour webinar showcasing the latest advancements in HALO AP® version 2.5. Indica Labs’ robust digital pathology platform has been enhanced to support multi-site deployments, new tools for the pathologist, enhanced toolkit for collaboration, and new Lab Logic capabilities. Hallie Rane, Associate Product Manager for Clinical Applications at Indica Labs, will demonstrate HALO AP’s Lab Logic capabilities, highlighting recent improvements and exciting new features that make it easier to configure workflows combining AI results, rules, thresholds, and manual review steps. Lab Logic brings these elements together in a single, cohesive model, giving labs more control over how decisions are made and actions are triggered across the platform.
Hallie will also highlight updates to the tumor board module version 2.0 and show attendees how the new tumor board features support complex diagnostics when multi-disciplinary collaboration is key. Hallie will also give a detailed overview of additional HALO AP 2.5 features which include robust functionality and improved support for multi-site institutions including smart slide lists and profiles; site-specific reporting on a single platform; secondary assignee workflows; and multi-specimen support for a truly comprehensive bench-to-bedside workflow.
Learning Objectives
- Understand the functionality of the HALO AP® platform and how it supports image and case management in anatomic pathology.
- Understand how Lab Logic provides a unified way to define, manage and automate workflow behavior across AI and manual processes.
- Discover new and improved collaboration tools for support of complex diagnostics and multi-disciplinary team meetings and learn how these new features support large medical institutions and multi-site deployments.
- Identify how the new features in HALO AP 2.5 work together to create a configurable, fully automatic, AI-ready workflow for bench-to-bedside support.
HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition, HALO AP® provides built-in compliance with FDA 21 CFR Part 11, HIPAA, and GDPR. WBS-MAR-000020v1
Presenter
Hallie Rane
Associate Product Manager for Clinical Applications
Indica Labs
Hallie Rane received a BS in biology from the University of New Mexico and has a background in molecular biology and evolution. Hallie joined Indica Labs in 2023 as the Product Specialist for HALO AP. Prior to Indica Labs, Hallie worked in both industry and academic positions and has held a variety of technical and customer-facing roles, where she collaborated with customers, scientists, and technicians to develop a diverse array of products. Her journey encompassed ventures into biotechnology innovation, academic research labs, and even the realm of craft beer production, where she served as Head Brewer.
SOURCE: Indica Labs
